The specialty cardiac care service, which began June 26 and will be offered one day per month, provides local access to ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced publication of successful multi-site validation of its software, which ...
The UnityPoint Clinic in Dubuque has expanded its cardiac care with a new electrophysiology clinic to care for heart rhythm ...
TheHealthSite on MSN
Endurance exercise linked to atrial fibrillation in middle-aged men with cycling linked to higher odds
A team of scientists led by Jarne De Paepe suggests middle-aged men with extensive endurance exercise histories may face higher odds of atrial fibrillation with cycling showing an independent ...
Tempus AI, Inc. (NASDAQ:TEM) is one of the 12 Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On. On June 11, 2026, ...
The approach should be considered to prevent leaks, which have been tied to increased stroke risks, Vivek Reddy says.
Sweden: Researchers have found in a new study that pre-cardioversion rhythm monitoring using smartphone-based ...
Inspire Medical's SLEEP 2026 updates spotlight new Inspire V data, remote patient tools and research supporting wider OSA therapy adoption.
Do omega-3 supplements affect blood sugar? Research shows mixed results, with little overall impact on glucose control in diabetes.
Eli Lilly and Company today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jaypirca (pirtobrutinib), a non ...
Inspire Medical Systems, Inc. (NYSE: INSP), a medical technology company focused on innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced its ...
Digoxin therapy may reduce the risk for new-onset or worsening heart failure in patients with symptomatic rheumatic heart disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results